Reviews
Evidence-Based Reviews
Using seclusion to prevent COVID-19 transmission on inpatient psychiatry units
Ethical factors guide seclusion of patients who test positive for COVID-19 or refuse testing.
Pearls
Pharmacogenetic testing: 5 Questions
Pharmacogenetic testing can potentially help improve medication adherence, reduce 'trial-and-error' prescribing, and target an effective treatment...
Out Of The Pipeline
Lemborexant for insomnia
Lemborexant, FDA-approved for the treatment of insomnia, has demonstrated efficacy in improving both sleep onset and sleep maintenance.
Evidence-Based Reviews
Negative symptoms of schizophrenia: An update
Treatment can be challenging, but research suggests several medications may hold promise.
Evidence-Based Reviews
Evaluating patients’ decision-making capacity during COVID-19
How to assess DMC in patients with COVID-19 or those who are afraid to seek treatment.
Pearls
Legal concerns after a patient suicide
We offer guidance on how to cope with a patient's completed suicide, and specifically address the legal concerns.
Pearls
Cannabis-derived compounds: What you need to know
This article reviews the current FDA-approved cannabis-related treatments and their indications, and concerns regarding CBD products.
Evidence-Based Reviews
Helping older adults overcome the challenges of technology
Interventions need to focus on both cognitive enhancement and functional skills training.
Evidence-Based Reviews
COVID-19 and patients with serious mental illness
This primer summarizes the clinical management of this easily forgotten group during a pandemic.
Evidence-Based Reviews
Cognitive-behavioral therapy for insomnia: A review of 8 studies
Evidence suggests CBT-I might benefit patients with comorbid depression, sleep apnea, or PTSD.
Pearls
Off-label prescribing: How to limit your liability
A step-by-step approach for helping to reduce your liability risk in off-label prescribing.